179 related articles for article (PubMed ID: 35523034)
41. Statins may increase the risk of being diagnosed with prostate cancer.
Brassetti A; Tedesco F; Cacciatore L; Prata F; Ragusa A; Iannuzzi A; Lombardo R; Tema G; Cicione A; Tubaro A; Simone G; DE Nunzio C
Minerva Urol Nephrol; 2024 Feb; 76(1):74-80. PubMed ID: 37795695
[TBL] [Abstract][Full Text] [Related]
42. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
[TBL] [Abstract][Full Text] [Related]
43. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
[TBL] [Abstract][Full Text] [Related]
44. Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER-Medicare Analysis.
Loomans-Kropp HA; Chaloux M; Richmond E; Umar A
Cancer Prev Res (Phila); 2021 Feb; 14(2):195-204. PubMed ID: 32998939
[TBL] [Abstract][Full Text] [Related]
45. Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease.
Byrne P; Cullinan J; Murphy C; Smith SM
BMJ Open; 2018 Feb; 8(2):e018524. PubMed ID: 29439070
[TBL] [Abstract][Full Text] [Related]
46. Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial.
Muller RL; Gerber L; Moreira DM; Andriole G; Castro-Santamaria R; Freedland SJ
Eur Urol; 2012 Nov; 62(5):757-64. PubMed ID: 22658758
[TBL] [Abstract][Full Text] [Related]
47. Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe.
Khunti K; Danese MD; Kutikova L; Catterick D; Sorio-Vilela F; Gleeson M; Kondapally Seshasai SR; Brownrigg J; Ray KK
JAMA Netw Open; 2018 Dec; 1(8):e185554. PubMed ID: 30646277
[TBL] [Abstract][Full Text] [Related]
48. The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk.
Miner M; Morgentaler A; Khera M; Traish AM
Clin Endocrinol (Oxf); 2018 Jul; 89(1):3-10. PubMed ID: 29486065
[TBL] [Abstract][Full Text] [Related]
49. The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysis.
Tan P; Wei S; Yang L; Tang Z; Cao D; Liu L; Lei J; Fan Y; Gao L; Wei Q
Sci Rep; 2016 Jul; 6():29106. PubMed ID: 27384548
[TBL] [Abstract][Full Text] [Related]
50. Serum Testosterone is Inversely and Sex Hormone-binding Globulin is Directly Associated with All-cause Mortality in Men.
Yeap BB; Marriott RJ; Antonio L; Chan YX; Raj S; Dwivedi G; Reid CM; Anawalt BD; Bhasin S; Dobs AS; Hankey GJ; Matsumoto AM; Norman PE; O'Neill TW; Ohlsson C; Orwoll ES; Vanderschueren D; Wittert GA; Wu FCW; Murray K
J Clin Endocrinol Metab; 2021 Jan; 106(2):e625-e637. PubMed ID: 33059368
[TBL] [Abstract][Full Text] [Related]
51. Mortality associated with statins in men with advanced prostate cancer treated with androgen deprivation therapy.
Wu SY; Fang SC; Shih HJ; Wen YC; Shao YJ
Eur J Cancer; 2019 May; 112():109-117. PubMed ID: 30827745
[TBL] [Abstract][Full Text] [Related]
52. Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010.
Jespersen CG; Nørgaard M; Friis S; Skriver C; Borre M
Cancer Epidemiol; 2014 Feb; 38(1):42-7. PubMed ID: 24275259
[TBL] [Abstract][Full Text] [Related]
53. Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness.
Morote J; Celma A; Planas J; Placer J; de Torres I; Olivan M; Carles J; Reventós J; Doll A
Int J Mol Sci; 2014 Aug; 15(8):13615-23. PubMed ID: 25101846
[TBL] [Abstract][Full Text] [Related]
54. Nonadherence to Statins and Antihypertensives and Hospitalizations Among Elderly Medicare Beneficiaries With Incident Cancer.
Chopra I; Dwibedi N; Mattes MD; Tan X; Findley P; Sambamoorthi U
J Natl Compr Canc Netw; 2017 Nov; 15(11):1351-1360. PubMed ID: 29118227
[No Abstract] [Full Text] [Related]
55. Using imputed pre-treatment cholesterol in a propensity score model to reduce confounding by indication: results from the multi-ethnic study of atherosclerosis.
Jorgensen NW; Sibley CT; McClelland RL
BMC Med Res Methodol; 2013 Jun; 13():81. PubMed ID: 23800038
[TBL] [Abstract][Full Text] [Related]
56. Symptomatic response rates to testosterone therapy and the likelihood of completing 12 months of therapy in clinical practice.
Rhoden EL; Morgentaler A
J Sex Med; 2010 Jan; 7(1 Pt 1):277-83. PubMed ID: 20104673
[TBL] [Abstract][Full Text] [Related]
57. Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer.
Harshman LC; Wang X; Nakabayashi M; Xie W; Valenca L; Werner L; Yu Y; Kantoff AM; Sweeney CJ; Mucci LA; Pomerantz M; Lee GS; Kantoff PW
JAMA Oncol; 2015 Jul; 1(4):495-504. PubMed ID: 26181260
[TBL] [Abstract][Full Text] [Related]
58. Interaction between Mediterranean diet and statins on mortality risk in patients with cardiovascular disease: Findings from the Moli-sani Study.
Bonaccio M; Di Castelnuovo A; Costanzo S; Persichillo M; De Curtis A; Cerletti C; Donati MB; de Gaetano G; Iacoviello L;
Int J Cardiol; 2019 Feb; 276():248-254. PubMed ID: 30527993
[TBL] [Abstract][Full Text] [Related]
59. Associations between statin use and progression in men with prostate cancer treated with primary androgen deprivation therapy.
Mikkelsen MK; Thomsen FB; Berg KD; Jarden M; Larsen SB; Hansen RB; Brasso K
Scand J Urol; 2017 Dec; 51(6):464-469. PubMed ID: 28831860
[TBL] [Abstract][Full Text] [Related]
60. Statins and cancer survivors: the need for structured guidelines.
Almuwaqqat Z; Hung O; Parashar S
Future Cardiol; 2018 Jan; 14(1):5-8. PubMed ID: 29168650
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
